Synexa Life Sciences has been a pioneer in the biomarker field for nearly 20 years.
August 10, 2022
ProtoTrials®
ProtoTrials® is a proprietary human in vitro translational immunology platform.
August 10, 2022
Bioanalytical Solutions for Immuno-oncology Therapeutics
Our speciality in immunology and immune-based analysis puts us at the forefront of driving immunotherapy development.
August 10, 2022
Measurement of phosphorylated SMAD-2/3
In fibrotic disease, deposition of extracellular matrix (ECM) proteins is increased. This compromises tissue architecture and interferes with normal organ function.
March 23, 2021
COVID-19: Biomarker Analysis
Synexa provides a large portfolio of biomarkers for COVID-19 therapeutic and vaccine development.
